BLTE

insider transactions

BELITE BIO, INC — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-27.5K

0 buy · 27.5K sell

Net value · 365d

-$4.8M

$0 in · $4.8M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 27.5K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Sell·S
Apr 29, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$3.5K

22 sh · $158.19

Own -0%
Sell·S
Apr 29, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$16.1K

102 sh · $157.39

Own -2%
Sell·S
Apr 29, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$53.0K

339 sh · $156.43

Own -6%
Sell·S
Apr 29, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$40.3K

259 sh · $155.52

Own -4%
Sell·S
Apr 29, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$43.0K

278 sh · $154.58

Own -4%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$8.8K

54 sh · $162.14

Own -1%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$14.4K

89 sh · $161.72

Own -1%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$19.2K

120 sh · $160.27

Own -2%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$60.6K

380 sh · $159.42

Own -5%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$9.8K

62 sh · $158.71

Own -1%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$35.0K

222 sh · $157.49

Own -3%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$8.3K

53 sh · $156.61

Own -1%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$1.2K

8 sh · $155.36

Own -0%
Sell·S
Apr 28, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$1.9K

12 sh · $154.65

Own -0%
Sell·S
Apr 27, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$5.9K

36 sh · $164.07

Own -0%
Sell·S
Apr 27, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$66.9K

409 sh · $163.56

Own -5%
Sell·S
Apr 27, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$37.5K

231 sh · $162.38

Own -3%
Sell·S
Apr 27, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$45.3K

280 sh · $161.62

Own -3%
Sell·S
Apr 27, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$7.1K

44 sh · $160.83

Own -1%
Sell·S
Apr 24, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$488

3 sh · $162.53

Own -0%
Sell·S
Apr 24, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$4.5K

28 sh · $161.22

Own -0%
Sell·S
Apr 24, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$52.9K

330 sh · $160.40

Own -4%
Sell·S
Apr 24, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$59.8K

375 sh · $159.46

Own -4%
Sell·S
Apr 24, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$30.1K

190 sh · $158.65

Own -2%
Sell·S
Apr 24, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$11.7K

74 sh · $157.86

Own -1%
Sell·S
Apr 23, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$3.6K

21 sh · $169.56

Own -0%
Sell·S
Apr 23, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$9.1K

54 sh · $168.43

Own -1%
Sell·S
Apr 23, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$62.4K

373 sh · $167.37

Own -4%
Sell·S
Apr 23, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$21.2K

127 sh · $166.56

Own -1%
Sell·S
Apr 23, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$26.1K

158 sh · $165.38

Own -2%
Sell·S
Apr 23, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$43.9K

267 sh · $164.47

Own -3%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$3.6K

21 sh · $173.04

Own -0%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$43.0K

249 sh · $172.49

Own -2%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$44.1K

257 sh · $171.62

Own -2%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$12.8K

75 sh · $170.58

Own -1%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$17.8K

105 sh · $169.52

Own -1%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$17.0K

101 sh · $168.64

Own -1%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$23.6K

141 sh · $167.42

Own -1%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$3.3K

20 sh · $166.32

Own -0%
Sell·S
Apr 22, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$5.1K

31 sh · $165.70

Own -0%
Sell·S
Apr 21, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$35.8K

214 sh · $167.34

Own -2%
Sell·S
Apr 21, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$51.9K

312 sh · $166.49

Own -3%
Sell·S
Apr 21, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$54.9K

332 sh · $165.49

Own -3%
Sell·S
Apr 21, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$12.8K

78 sh · $164.60

Own -1%
Sell·S
Apr 21, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$10.5K

64 sh · $163.49

Own -1%
Other·J
Apr 21, 26

Yu-Hsin Lin KEY

Chief Executive Officer

$0

10.0K sh
Other·J
Apr 21, 26

Hendrik Peter Scholl

Chief Medical Officer

$0

10.0K sh
Other·J
Apr 21, 26

Hao-Yuan Chuang KEY

Chief Financial Officer

$0

10.0K sh
Sell·S
Apr 20, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$1.5K

9 sh · $168.35

Own -0%
Sell·S
Apr 20, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$2.7K

16 sh · $167.17

Own -0%
Sell·S
Apr 20, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$501

3 sh · $166.91

Own -0%
Sell·S
Apr 20, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$6.6K

40 sh · $165.29

Own -0%
Sell·S
Apr 20, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$20.4K

124 sh · $164.40

Own -1%
Sell·S
Apr 20, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$85.7K

524 sh · $163.52

Own -4%
Sell·S
Apr 20, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$46.2K

284 sh · $162.76

Own -2%
Sell·S
Apr 17, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$32.7K

200 sh · $163.33

Own -1%
Sell·S
Apr 17, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$35.1K

216 sh · $162.48

Own -2%
Sell·S
Apr 17, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$44.2K

274 sh · $161.41

Own -2%
Sell·S
Apr 17, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$36.3K

226 sh · $160.55

Own -2%
Sell·S
Apr 17, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$8.3K

52 sh · $159.38

Own -0%
Sell·S
Apr 17, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$5.1K

32 sh · $158.46

Own -0%
Sell·S
Apr 16, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$2.0K

12 sh · $164.12

Own -0%
Sell·S
Apr 16, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$5.9K

36 sh · $163.21

Own -0%
Sell·S
Apr 16, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$12.3K

76 sh · $162.26

Own -1%
Sell·S
Apr 16, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$38.8K

240 sh · $161.61

Own -2%
Sell·S
Apr 16, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$32.2K

201 sh · $160.35

Own -1%
Sell·S
Apr 16, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$35.0K

219 sh · $159.81

Own -1%
Sell·S
Apr 16, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$34.2K

216 sh · $158.28

Own -1%
Sell·S
Apr 15, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$685

4 sh · $171.19

Own -0%
Sell·S
Apr 15, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$1.4K

8 sh · $170.77

Own -0%
Sell·S
Apr 15, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$11.5K

68 sh · $169.15

Own -0%
Sell·S
Apr 15, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$90.6K

537 sh · $168.64

Own -3%
Sell·S
Apr 15, 26

Nathan L. Mata

Chief Scientific Officer · 10b5-1

$64.2K

383 sh · $167.58

Own -2%
Sell·S
Apr 9, 26

Yu-Hsin Lin KEY

Chief Executive Officer · 10b5-1

$36.6K

200 sh · $183.00

Own -0%
Sell·S
Apr 9, 26

Yu-Hsin Lin KEY

Chief Executive Officer · 10b5-1

$547.2K

3.0K sh · $182.40

Own -2%
Sell·S
Apr 9, 26

Yu-Hsin Lin KEY

Chief Executive Officer · 10b5-1

$634.7K

3.5K sh · $181.33

Own -2%
Sell·S
Apr 9, 26

Yu-Hsin Lin KEY

Chief Executive Officer · 10b5-1

$450.9K

2.5K sh · $180.36

Own -1%
Sell·S
Apr 9, 26

Wan-Shan Chen

Director · 10b5-1

$198.5K

1.1K sh · $180.43

Own -11%
Sell·S
Apr 9, 26

Hao-Yuan Chuang KEY

Chief Financial Officer · 10b5-1

$53.3K

291 sh · $183.08

Own -0%
Sell·S
Apr 9, 26

Hao-Yuan Chuang KEY

Chief Financial Officer · 10b5-1

$348.5K

1.9K sh · $182.58

Own -2%
Sell·S
Apr 9, 26

Hao-Yuan Chuang KEY

Chief Financial Officer · 10b5-1

$362.8K

2.0K sh · $181.40

Own -2%
Sell·S
Apr 9, 26

Hao-Yuan Chuang KEY

Chief Financial Officer · 10b5-1

$360.7K

2.0K sh · $180.35

Own -2%
Grant·A
Mar 31, 26

Wan-Shan Chen

Director

$0

13.8K sh

Own New
Grant·A
Mar 31, 26

Hao-Yuan Chuang KEY

Chief Financial Officer

$0

144.9K sh

Own +100%
Grant·A
Mar 31, 26

Nathan L. Mata

Chief Scientific Officer

$0

144.9K sh

Own +118%
Grant·A
Mar 31, 26

Yu-Hsin Lin KEY

Chief Executive Officer

$0

207.0K sh

Own +100%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Apr 29, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	22	-0%	$158.19	$3.5K
Apr 29, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	102	-2%	$157.39	$16.1K
Apr 29, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	339	-6%	$156.43	$53.0K
Apr 29, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	259	-4%	$155.52	$40.3K
Apr 29, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	278	-4%	$154.58	$43.0K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	54	-1%	$162.14	$8.8K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	89	-1%	$161.72	$14.4K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	120	-2%	$160.27	$19.2K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	380	-5%	$159.42	$60.6K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	62	-1%	$158.71	$9.8K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	222	-3%	$157.49	$35.0K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	53	-1%	$156.61	$8.3K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	8	-0%	$155.36	$1.2K
Apr 28, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	12	-0%	$154.65	$1.9K
Apr 27, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	36	-0%	$164.07	$5.9K
Apr 27, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	409	-5%	$163.56	$66.9K
Apr 27, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	231	-3%	$162.38	$37.5K
Apr 27, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	280	-3%	$161.62	$45.3K
Apr 27, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	44	-1%	$160.83	$7.1K
Apr 24, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	3	-0%	$162.53	$488
Apr 24, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	28	-0%	$161.22	$4.5K
Apr 24, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	330	-4%	$160.40	$52.9K
Apr 24, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	375	-4%	$159.46	$59.8K
Apr 24, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	190	-2%	$158.65	$30.1K
Apr 24, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	74	-1%	$157.86	$11.7K
Apr 23, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	21	-0%	$169.56	$3.6K
Apr 23, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	54	-1%	$168.43	$9.1K
Apr 23, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	373	-4%	$167.37	$62.4K
Apr 23, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	127	-1%	$166.56	$21.2K
Apr 23, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	158	-2%	$165.38	$26.1K
Apr 23, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	267	-3%	$164.47	$43.9K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	21	-0%	$173.04	$3.6K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	249	-2%	$172.49	$43.0K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	257	-2%	$171.62	$44.1K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	75	-1%	$170.58	$12.8K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	105	-1%	$169.52	$17.8K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	101	-1%	$168.64	$17.0K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	141	-1%	$167.42	$23.6K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	20	-0%	$166.32	$3.3K
Apr 22, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	31	-0%	$165.70	$5.1K
Apr 21, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	214	-2%	$167.34	$35.8K
Apr 21, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	312	-3%	$166.49	$51.9K
Apr 21, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	332	-3%	$165.49	$54.9K
Apr 21, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	78	-1%	$164.60	$12.8K
Apr 21, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	64	-1%	$163.49	$10.5K
Apr 21, 2026	Yu-Hsin Lin KEY	Chief Executive Officer	Other J	10.0K	—	—	$0
Apr 21, 2026	Hendrik Peter Scholl	Chief Medical Officer	Other J	10.0K	—	—	$0
Apr 21, 2026	Hao-Yuan Chuang KEY	Chief Financial Officer	Other J	10.0K	—	—	$0
Apr 20, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	9	-0%	$168.35	$1.5K
Apr 20, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	16	-0%	$167.17	$2.7K
Apr 20, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	3	-0%	$166.91	$501
Apr 20, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	40	-0%	$165.29	$6.6K
Apr 20, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	124	-1%	$164.40	$20.4K
Apr 20, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	524	-4%	$163.52	$85.7K
Apr 20, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	284	-2%	$162.76	$46.2K
Apr 17, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	200	-1%	$163.33	$32.7K
Apr 17, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	216	-2%	$162.48	$35.1K
Apr 17, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	274	-2%	$161.41	$44.2K
Apr 17, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	226	-2%	$160.55	$36.3K
Apr 17, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	52	-0%	$159.38	$8.3K
Apr 17, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	32	-0%	$158.46	$5.1K
Apr 16, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	12	-0%	$164.12	$2.0K
Apr 16, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	36	-0%	$163.21	$5.9K
Apr 16, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	76	-1%	$162.26	$12.3K
Apr 16, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	240	-2%	$161.61	$38.8K
Apr 16, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	201	-1%	$160.35	$32.2K
Apr 16, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	219	-1%	$159.81	$35.0K
Apr 16, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	216	-1%	$158.28	$34.2K
Apr 15, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	4	-0%	$171.19	$685
Apr 15, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	8	-0%	$170.77	$1.4K
Apr 15, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	68	-0%	$169.15	$11.5K
Apr 15, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	537	-3%	$168.64	$90.6K
Apr 15, 2026	Nathan L. Mata 10b5-1	Chief Scientific Officer	Sell S	383	-2%	$167.58	$64.2K
Apr 9, 2026	Yu-Hsin Lin KEY 10b5-1	Chief Executive Officer	Sell S	200	-0%	$183.00	$36.6K
Apr 9, 2026	Yu-Hsin Lin KEY 10b5-1	Chief Executive Officer	Sell S	3.0K	-2%	$182.40	$547.2K
Apr 9, 2026	Yu-Hsin Lin KEY 10b5-1	Chief Executive Officer	Sell S	3.5K	-2%	$181.33	$634.7K
Apr 9, 2026	Yu-Hsin Lin KEY 10b5-1	Chief Executive Officer	Sell S	2.5K	-1%	$180.36	$450.9K
Apr 9, 2026	Wan-Shan Chen 10b5-1	Director	Sell S	1.1K	-11%	$180.43	$198.5K
Apr 9, 2026	Hao-Yuan Chuang KEY 10b5-1	Chief Financial Officer	Sell S	291	-0%	$183.08	$53.3K
Apr 9, 2026	Hao-Yuan Chuang KEY 10b5-1	Chief Financial Officer	Sell S	1.9K	-2%	$182.58	$348.5K
Apr 9, 2026	Hao-Yuan Chuang KEY 10b5-1	Chief Financial Officer	Sell S	2.0K	-2%	$181.40	$362.8K
Apr 9, 2026	Hao-Yuan Chuang KEY 10b5-1	Chief Financial Officer	Sell S	2.0K	-2%	$180.35	$360.7K
Mar 31, 2026	Wan-Shan Chen	Director	Grant A	13.8K	New	—	$0
Mar 31, 2026	Hao-Yuan Chuang KEY	Chief Financial Officer	Grant A	144.9K	+100%	—	$0
Mar 31, 2026	Nathan L. Mata	Chief Scientific Officer	Grant A	144.9K	+118%	—	$0
Mar 31, 2026	Yu-Hsin Lin KEY	Chief Executive Officer	Grant A	207.0K	+100%	—	$0

About BLTE insider trading

This page tracks insider transactions for BELITE BIO, INC (BLTE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.